Skip to search formSkip to main contentSkip to account menu

Tumor-Associated Trypsin Inhibitor

Known as: Trypsin Inhibitor, Tumor Associated, Tumor Associated Trypsin Inhibitor, Trypsin Inhibitor, Tumor-Associated 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Serine protease inhibitor Kazal type 1 (SPINK1) was originally identified as a trypsin inhibitor by Kazal et al. in 1948. SPINK1… 
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Colorectal cancer (CRC) is one of the most serious… 
2010
2010
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Serine protease inhibitor Kazal type 1 (SPINK1… 
2007
2007
After the discovery of estrogen receptor beta (ERβ) in 1995, it became clear that in many “non-classical” estrogen-responsive… 
2001
2001
Chromogranin A (CGA) is a low MW (49,000) acidic hydrophilic protein. It is synthesized in the chromaffm granules of the… 
1998
1998
TATI (tumor associated trypsin inhibitor) is a low molecular weight protein employed as a tumor marker. To evaluate the role of… 
1992
1992
189 clinical and serological examinations were performed in 30 patients before treatment and during follow up of squamous cell…